FAQs

What is DermaBind’s regulatory classification?

DermaBind TL, FM, and CH are Section 361 Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), regulated under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. This classification reflects that the products are minimally processed and intended for homologous use, with no systemic effect on the recipient.

What wound types is DermaBind indicated for?

DermaBind TL and FM are designed for use as protective wound coverings on partial- and full-thickness acute and chronic wounds, including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure injuries, trauma wounds, and dehisced wounds. DermaBind CH is formulated specifically for dental applications, including periodontal, gingival, and alveolar ridge procedures.

How does reimbursement work for DermaBind TL and FM?

DermaBind TL is billed under CPT Q4225, and DermaBind FM under CPT Q4313. Medicare contractors cover both products for DFUs and VLUs, subject to applicable Local Coverage Determinations (LCDs). Both products are also eligible for billing across other qualifying wound types. Our team provides pre-treatment coverage verification and documentation support through the Clinical Stewardship Program. Contact reimbursement@healthtechwc.com for practice-specific guidance.

What is the difference between DermaBind TL and DermaBind FM?

Both DermaBind TL and FM are dehydrated full-membrane placental wound coverings that preserve all native layers including the amnion, spongy layer, and chorion. DermaBind FM features a distinct orientation notch that aids precise placement, making it particularly suited for surgeons who prefer tactile landmarks during application. Clinical selection between the two products is at the discretion of the treating physician.

Does DermaBind use any chemicals or preservatives in processing?

No. DermaBind undergoes a proprietary preservation method that uses no unnecessary chemicals, antibiotics, or preservatives, and the product is never frozen. Controlled dehydration maintains all native tissue architecture. Terminal sterilization to SAL 10⁻⁶ ensures product sterility without compromising the extracellular matrix.

How is donor tissue sourced and screened?

Tissue is ethically sourced from full-term live births (over 34 weeks gestation). All donors undergo comprehensive maternal health evaluations, including a 150-question lifestyle and medical history interview, full laboratory testing, and screening in accordance with FDA standards under 21 CFR 1271 and Section 361 of the Public Health Service Act.

What storage conditions does DermaBind require?

DermaBind TL and FM may be stored at room temperature for up to 5 years. DermaBind CH has a 3-year shelf life at ambient temperature. No refrigeration or freezing is required. This simplifies inventory management across wound centers, mobile practices, and long-term care settings.

What does the Clinical Stewardship Program include?

The Clinical Stewardship Program is a comprehensive support infrastructure available to every DermaBind practice partner. It includes pre-treatment benefits verification, clinical education, application guidance, documentation support, and billing assistance. The program is designed to reduce administrative burden and protect your practice’s compliance posture so that your clinical attention stays focused on patient outcomes.

FAQs

What is DermaBind’s regulatory classification?

DermaBind TL, FM, and CH are Section 361 Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), regulated under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. This classification reflects that the products are minimally processed and intended for homologous use, with no systemic effect on the recipient.

What wound types is DermaBind indicated for?

DermaBind TL and FM are designed for use as protective wound coverings on partial- and full-thickness acute and chronic wounds, including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure injuries, trauma wounds, and dehisced wounds. DermaBind CH is formulated specifically for dental applications, including periodontal, gingival, and alveolar ridge procedures.

How does reimbursement work for DermaBind TL and FM?

DermaBind TL is billed under CPT Q4225, and DermaBind FM under CPT Q4313. Medicare contractors cover both products for DFUs and VLUs, subject to applicable Local Coverage Determinations (LCDs). Both products are also eligible for billing across other qualifying wound types. Our team provides pre-treatment coverage verification and documentation support through the Clinical Stewardship Program. Contact reimbursement@healthtechwc.com for practice-specific guidance.

What is the difference between DermaBind TL and DermaBind FM?

Both DermaBind TL and FM are dehydrated full-membrane placental wound coverings that preserve all native layers including the amnion, spongy layer, and chorion. DermaBind FM features a distinct orientation notch that aids precise placement, making it particularly suited for surgeons who prefer tactile landmarks during application. Clinical selection between the two products is at the discretion of the treating physician.

Does DermaBind use any chemicals or preservatives in processing?

No. DermaBind undergoes a proprietary preservation method that uses no unnecessary chemicals, antibiotics, or preservatives, and the product is never frozen. Controlled dehydration maintains all native tissue architecture. Terminal sterilization to SAL 10⁻⁶ ensures product sterility without compromising the extracellular matrix.

How is donor tissue sourced and screened?

Tissue is ethically sourced from full-term live births (over 34 weeks gestation). All donors undergo comprehensive maternal health evaluations, including a 150-question lifestyle and medical history interview, full laboratory testing, and screening in accordance with FDA standards under 21 CFR 1271 and Section 361 of the Public Health Service Act.

What storage conditions does DermaBind require?

DermaBind TL and FM may be stored at room temperature for up to 5 years. DermaBind CH has a 3-year shelf life at ambient temperature. No refrigeration or freezing is required. This simplifies inventory management across wound centers, mobile practices, and long-term care settings.

What does the Clinical Stewardship Program include?

The Clinical Stewardship Program is a comprehensive support infrastructure available to every DermaBind practice partner. It includes pre-treatment benefits verification, clinical education, application guidance, documentation support, and billing assistance. The program is designed to reduce administrative burden and protect your practice’s compliance posture so that your clinical attention stays focused on patient outcomes.